Application of Various Optical and Electrochemical Nanobiosensors for Detecting Cancer Antigen 125 (CA-125): A Review.
Mehrab PourmadadiAli MoammeriAmin ShamsabadipourYasamin Farahanian MoghaddamAbbas RahdarSadanand PandeyPublished in: Biosensors (2023)
Nowadays, diagnosing early-stage cancers can be vital for saving patients and dramatically decreases mortality rates. Therefore, specificity and sensitivity in the detection of cancer antigens should be elaborately ensured. Some early-stage cancers can be diagnosed via detecting the cancer antigen CA-125, such as ovarian cancer, and required treatments can be applied more efficiently. Thus, detection of CA-125 by employing various optical or electrochemical biosensors is a preliminary and crucial step to treating cancers. In this review, a diverse range of optical and electrochemical means of detecting CA-125 are reviewed. Furthermore, an applicable comparison of their performance and sensitivity is provided, several commercial detection kits are investigated, and their applications are compared and discussed to determine whether they are applicable and accurate enough.
Keyphrases
- label free
- early stage
- papillary thyroid
- high resolution
- gold nanoparticles
- squamous cell
- childhood cancer
- newly diagnosed
- ionic liquid
- loop mediated isothermal amplification
- protein kinase
- high speed
- cardiovascular disease
- molecularly imprinted
- type diabetes
- prognostic factors
- squamous cell carcinoma
- risk factors
- dendritic cells
- neoadjuvant chemotherapy
- coronary artery disease
- sentinel lymph node
- quantum dots
- rectal cancer
- locally advanced